News & Updates

Vitamin C supplementation in pregnant smokers boosts offspring’s respiratory health

Supplementation with vitamin C in pregnant women appears to minimize the effects of smoking on childhood respiratory health, with a recent study showing that it is associated with increased airway function and lower occurrence of wheeze among children born to mothers who smoked during pregnancy.

More evidence supports osimertinib for EGFR-mutated NSCLC

Safety data from the phase III ADAURA study support osimertinib as an effective adjuvant therapy for resectable, stage IB–IIIA EGFR-mutated non–small-cell lung cancer (NSCLC), says an expert.

Original New Drug Application Approvals by US FDA (1 - 15 December 2022)

New drug applications approved by US FDA as of 01 - 15 December 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Increased oxygen exposure during surgery ups risk of kidney, heart, lung injuries

Increased intraoperative exposure to oxygen appears to heighten the incidence of renal, cardiac, and pulmonary injuries, according to the results of an observational cohort study, noting that residual confounding of these associations cannot be excluded.

Multipathogen testing an essential part of Test-Target-Treat strategy for respiratory illnesses

At a recent webinar, experts discussed the paradigm shift in respiratory illnesses and treatment practices as the COVID-19 pandemic transitions to an endemic phase. The late Dr Mohan Ravuru, Physician Researcher and former Asia Pacific Medical Director, Abbott, Dr Johnny Sinon, Senior Emergency Physician from Makati Medical Center, Philippines, and Associate Professor Nuntra Suwantarat, Infectious Disease Specialist, from Chulabhorn International College of Medicine, Thammasat University, Thailand, delivered informative presentations and engaged the audience through a stimulating panel discussion.

Among the topics covered were the ‘immunity debt’ phenomenon leading to potential epidemics, challenges in the differential diagnosis of COVID-19 and influenza, and the importance of point-of-care, multipathogen testing as a part of the Test-Target-Treat strategy in respiratory diseases.